Hypersensitivity reaction to cancer chemotherapy.
D000743:Anemia, Hemolytic / Q000139:chemically induced; D000873:Anthracenes / Q000009:adverse effects / Q000097:blood; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects / Q000097:blood; D002945:Cisplatin / Q000009:adverse effects / Q000097:blood; D003877:Dermatitis, Contact / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced; D007105:Immune Complex Diseases / Q000139:chemically induced
D000873:Anthracenes; D000970:Antineoplastic Agents; C031404:bisantrene; D001215:Asparaginase; D002945:Cisplatin